Aravive Analyst Ratings
Aravive Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/22/2023 | 21.95% | Cantor Fitzgerald | $18 → $0.25 | Downgrades | Overweight → Neutral |
| 08/03/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 08/03/2023 | — | EF Hutton | Downgrades | Buy → Hold | |
| 08/03/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 08/03/2023 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/21/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/17/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/10/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 8680.49% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight |
| 06/05/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 06/05/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/25/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/25/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/17/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/11/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 03/16/2023 | 5753.66% | HC Wainwright & Co. | $7 → $12 | Maintains | Buy |
| 02/21/2023 | 3314.63% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/14/2023 | 4778.05% | EF Hutton | → $10 | Maintains | Buy |
| 01/05/2023 | 4778.05% | EF Hutton | → $10 | Initiates Coverage On | → Buy |
| 11/14/2022 | 875.61% | Piper Sandler | $6 → $2 | Maintains | Overweight |
| 10/25/2022 | 3314.63% | HC Wainwright & Co. | $26 → $7 | Maintains | Buy |
| 06/03/2022 | 7217.07% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 03/08/2021 | 12582.93% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 09/18/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/23/2020 | 12582.93% | HC Wainwright & Co. | $15 → $26 | Maintains | Buy |
| 03/27/2020 | 7217.07% | HC Wainwright & Co. | $25 → $15 | Maintains | Buy |
| 12/20/2019 | 12095.12% | HC Wainwright & Co. | $31 → $25 | Maintains | Buy |
| 12/10/2019 | 14534.15% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
| 11/20/2019 | 15021.95% | HC Wainwright & Co. | $18 → $31 | Reiterates | → Buy |
| 11/19/2019 | 17460.98% | Piper Sandler | $15 → $36 | Maintains | Overweight |
| 10/10/2019 | 8680.49% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 05/13/2019 | 4778.05% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 04/09/2019 | 6729.27% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/22/2023 | 21.95% | 坎托·菲茨杰拉德 | 18 美元 → 0.25 美元 | 降级 | 超重 → 中性 |
| 08/03/2023 | — | 威廉布莱尔 | 降级 | 跑赢大盘 → 市场表现 | |
| 08/03/2023 | — | EF Hutton | 降级 | 买入 → 持有 | |
| 08/03/2023 | — | HC Wainwright & Co. | 降级 | 买入 → 中性 | |
| 08/03/2023 | — | BTIG | 降级 | 买入 → 中性 | |
| 07/21/2023 | 8680.49% | 坎托·菲茨杰拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 07/17/2023 | 8680.49% | 坎托·菲茨杰拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 07/10/2023 | 8680.49% | 坎托·菲茨杰拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 07/03/2023 | 8680.49% | 坎托·菲茨杰拉德 | 18 美元 → 18 美元 | 重申 | 超重 → 超重 |
| 06/05/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 购买 → 购买 |
| 06/05/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 购买 → 购买 |
| 05/26/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 购买 → 购买 |
| 05/26/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 购买 → 购买 |
| 05/25/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 购买 → 购买 |
| 05/25/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 购买 → 购买 |
| 05/17/2023 | 8680.49% | 坎托·菲茨杰拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 05/11/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 购买 → 购买 |
| 05/11/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 购买 → 购买 |
| 03/16/2023 | 5753.66% | HC Wainwright & Co. | 7 美元 → 12 美元 | 维护 | 购买 |
| 02/21/2023 | 3314.63% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 02/14/2023 | 4778.05% | EF Hutton | → 10 美元 | 维护 | 购买 |
| 01/05/2023 | 4778.05% | EF Hutton | → 10 美元 | 启动覆盖开启 | → 购买 |
| 11/14/2022 | 875.61% | 派珀·桑德勒 | 6 美元 → 2 美元 | 维护 | 超重 |
| 10/25/2022 | 3314.63% | HC Wainwright & Co. | 26 美元 → 7 美元 | 维护 | 购买 |
| 06/03/2022 | 7217.07% | 罗斯资本 | → 15 美元 | 启动覆盖开启 | → 购买 |
| 2021 年 8 月 3 日 | 12582.93% | BTIG | → 26 美元 | 启动覆盖开启 | → 购买 |
| 09/18/2020 | — | 威廉布莱尔 | 启动覆盖开启 | → 跑赢大盘 | |
| 2020 年 7 月 23 日 | 12582.93% | HC Wainwright & Co. | 15 美元 → 26 美元 | 维护 | 购买 |
| 2020 年 3 月 27 日 | 7217.07% | HC Wainwright & Co. | 25 美元 → 15 美元 | 维护 | 购买 |
| 12/20/2019 | 12095.12% | HC Wainwright & Co. | 31 美元 → 25 美元 | 维护 | 购买 |
| 2019 年 10 月 12 日 | 14534.15% | 坎托·菲茨杰拉德 | → 30 美元 | 启动覆盖开启 | → 超重 |
| 2019 年 11 月 20 日 | 15021.95% | HC Wainwright & Co. | 18 美元 → 31 美元 | 重申 | → 购买 |
| 11/19/2019 | 17460.98% | 派珀·桑德勒 | 15 美元 → 36 美元 | 维护 | 超重 |
| 10/10/2019 | 8680.49% | HC Wainwright & Co. | → 18 美元 | 启动覆盖开启 | → 购买 |
| 2019 年 5 月 13 日 | 4778.05% | 派珀·桑德勒 | → 10 美元 | 启动覆盖开启 | → 超重 |
| 2019 年 9 月 4 日 | 6729.27% | Wedbush | → 14 美元 | 启动覆盖开启 | → 跑赢大盘 |
What is the target price for Aravive (ARAV)?
Aravive (ARAV) 的目标价格是多少？
The latest price target for Aravive (NASDAQ: ARAV) was reported by Cantor Fitzgerald on August 22, 2023. The analyst firm set a price target for $0.25 expecting ARAV to rise to within 12 months (a possible 21.95% upside). 24 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2023年8月22日公布了Aravive（纳斯达克股票代码：ARAV）的最新目标股价。该分析公司将目标股价定为0.25美元，预计ARAV将在12个月内上涨至21.95％（可能上涨21.95％）。去年有24家分析公司公布了评级。
What is the most recent analyst rating for Aravive (ARAV)?
分析师对Aravive（ARAV）的最新评级是多少？
The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by Cantor Fitzgerald, and Aravive downgraded their neutral rating.
坎托·菲茨杰拉德提供了Aravive（纳斯达克股票代码：ARAV）的最新分析师评级，Aravive下调了中性评级。
When is the next analyst rating going to be posted or updated for Aravive (ARAV)?
Aravive（ARAV）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Aravive的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Aravive的最后一次评级是在2023年8月22日提交的，因此你应该预计下一个评级将在2024年8月22日左右公布。
Is the Analyst Rating Aravive (ARAV) correct?
分析师评级 Aravive (ARAV) 正确吗？
While ratings are subjective and will change, the latest Aravive (ARAV) rating was a downgraded with a price target of $18.00 to $0.25. The current price Aravive (ARAV) is trading at is $0.21, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Aravive（ARAV）评级已下调，目标股价为18.00美元至0.25美元。Aravive（ARAV）目前的交易价格为0.21美元，超出了分析师的预测区间。